Eleven scientists from St. Jude Children’s Research Hospital have been honored on the 2024 Highly Cited Researchers list, acknowledging their significant contributions to their fields. The list, created by the Web of Science™ and ISI™ analysts, highlights researchers whose works have made a substantial impact globally. St. Jude leads medical research in pediatric care, significantly improving childhood cancer survival rates, while actively sharing breakthroughs with the global community.
In a remarkable achievement, eleven scientists from St. Jude Children’s Research Hospital have been recognized on the prestigious 2024 Highly Cited Researchers list. Compiled by the Web of Science™ alongside qualitative analysis from the Institute for Scientific Information (ISI)™ at Clarivate, this annual list celebrates researchers who have made significant contributions to their fields, establishing their influence globally.
The term “Highly Cited Researcher” is awarded to those whose work has placed them among the top 1% of cited scientists in their respective fields over the last decade. This recognition highlights how often their research is referenced by peers, emphasizing the impact of their findings on further scientific inquiry and the enhancement of patient care.
Kelly Caudle, PharmD, PhD, from the Department of Pharmacy and Pharmaceutical Sciences, commented on the meaning of citations: “Citations form a foundational layer of knowledge that enable the scientific community to build on existing discoveries and advance research and patient care with confidence.”
The distinguished St. Jude researchers come from a variety of departments, each excelling in their specific areas:
– Brian Abraham, PhD – Computational Biology
– Kelly Caudle, PharmD, PhD – Pharmacy and Pharmaceutical Sciences
– Hongbo Chi, PhD – Immunology
– Douglas Green, PhD – Immunology
– Thirumala-Devi Kanneganti, PhD – Immunology (Vice-chair)
– RK Subbarao Malireddi, PhD – Immunology (Kanneganti Lab)
– Tanja Mittag, PhD – Structural Biology
– Mary Relling, PharmD – Pharmacy and Pharmaceutical Sciences (Emeritus)
– Paul Thomas, PhD – Host-Microbe Interactions and Immunology
– Shengdar Tsai, PhD – Hematology
– Peter Vogel, DVM, PhD – Pathology
This year’s list includes 6,636 researchers representing 59 countries, with a notable 36.4% hailing from institutions in the United States. One honored researcher, Shengdar Tsai, remarked, “I’m honored to have been named to the Highly Cited Researcher list over the past several years. It’s a reflection of the broad impact of our work on genome editing technologies and therapies.”
St. Jude Children’s Research Hospital is a leading force in combatting childhood cancer, sickle cell disease, and other life-threatening illnesses. As the only National Cancer Institute-designated Comprehensive Cancer Center dedicated solely to children, treatments developed here have skyrocketed the childhood cancer survival rate from a mere 20% to an impressive 80% since the institution’s inception over six decades ago. The hospital diligently shares its groundbreaking discoveries to assist healthcare providers worldwide in elevating treatment standards for children.
For more insights, visit stjude.org, explore St. Jude Progress, the digital magazine, or connect with them on social media at @stjuderesearch.
The recognition of eleven scientists from St. Jude Children’s Research Hospital on the 2024 Highly Cited Researchers list underscores their influential contributions to medical research. Through their innovative work, they not only advance scientific knowledge but also substantially improve patient care. St. Jude continues to lead in combatting childhood illnesses, making remarkable strides to enhance survival rates and share their findings globally, fostering a collaborative approach to pediatric treatment.
Original Source: www.stjude.org
